Euro Psychiatric Nursing Market Analysis and Reports | Netherlands Conference Series

Market Analysis - Euro Psychiatric Nursing 2019

About the conference:

Euro Psychiatric Nursing welcomes attendees, presenters, and exhibitors from all over the world to Amsterdam, Netherlands. We are delighted to invite you all to attend and register for the “2nd Annual Congress on Psychiatric and Mental Health Nursing which is going to be held during October 21-22, 2019 at Amsterdam, Netherlands. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at Euro Psychiatric Nursing 2019, where you will be sure to have a meaningful experience with scholars from around the world. All the organizing committee members of Euro Psychiatric Nursing-2019 looking forward to meet you at Amsterdam, Netherlands

 

Importance and Scope:

Euro Psychiatric Nursing 2019 addresses current & future trends at the interface of Psychiatry and Nursing. It emphasizes on the use of various treatment methods for Psychiatric and Mental disorders. Psychiatric Nursing is combination of both Psychiatry & Nursing which focuses on disorders related to mental disorders, in which many cases were revealed to be originated from a recognizable malfunction in the brain. The trained psychiatrist’s works along with additional neuroscience clinicians to deliver complete care to the patients. On the other hand Nurses are responsible for assessing patient, giving medicines and treatments and also develops and manage nursing care plans. The global nurse call equipment system market size was valued at USD 870 million in 2016 and is projected to grow at a CAGR of 13.7% over the forecast period. North America followed by Europe is dominating the global nursing care market due to high healthcare expenditures. The U.S. is dominating the North American nursing care market due to increasing prevalence of diseases. Asia is expected to show high growth rate in the next five years.

 

Why Netherlands?

Approximately one in four people in the Netherlands will, at one point in their live, come in contact with a depression or an anxiety disorder. The burden of disease from these ailments is considerable: they account for diminished functioning, a lot of absence from work, high costs for society and even for the development of other physical illness. It is for that reason that the World Health Organisation has estimated that depression, because of its impact on quality of life; in the year 2020 will be ‘public illness number one’ in every western country. The Dutch Study for Depression and Anxiety (NESDA) began in 2004. The study contains a group of about 3000 participants with and without psychiatric symptoms, recruited through General Practitioner offices and mental health institutions in three regions in the Netherlands. NESDA is collaboration between various mental health institutions, universities and disciplines.

One of the NESDA findings includes the big overlap between depression and anxiety disorders: they mutually occur with over 70 per cent of the participants. Furthermore there is a clear connection between depression and anxiety and physical health. Within NESDA a lot of attention goes to genetic research and to biological research for the role of disrupted stress systems in the body. But the influence of psychological and environmental factors, such as personality or important life events, are also looked at extensively